Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
In an open letter, Sanofi Chief Executive Officer Paul Hudson today outlined several key projects that the company will implement to increase the...
The U.S. Food and Drug Administration (FDA) has approved Sarclisa® (isatuximab-irfc) in combination with carfilzomib and dexamethasone (Kd), for the...
Sanofi has won the prestigious International Society for Pharmaceutical Engineering (ISPE) Overall Facility of the Year Award for its...
Sanofi and the Parkinson's Foundation today announced a new research collaboration to advance the availability of genetic testing and counseling for...
Sanofi Genzyme today announced that new data from across the company's neurology portfolio will be presented at MSVirtual2020, the 8th Joint Americas ...
Sanofi and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will present new, positive data for PD-1 inhibitor Libtayo® (cemiplimab) at the European...
Sanofi and Principia Biopharma Inc. (NASDAQ: PRNB), a late-stage biopharmaceutical company focused on developing treatments for immune-mediated...
Sanofi (NASDAQ: SNY; EURONEXT: SAN) Experience the interactive Multichannel News Release here:...
Sanofi Pasteur, the vaccines global business unit of Sanofi, today shipped the first of its influenza vaccine doses to health care providers in the U....
Sanofi and The University of Texas MD Anderson Cancer Center today announced a five-year strategic collaboration to accelerate the development of...
The U.S. Food and Drug Administration (FDA) has approved a 300 mg single-dose pre-filled pen for Dupixent® (dupilumab). The pre-filled pen is...
Preclinical data for Sanofi's investigational compounds in breast, lung, multiple myeloma and other cancers will be featured at the American Academy...
Sanofi and Sobi™, together with the World Federation of Hemophilia (WFH) and WFH USA, today announced an extension of their support of the WFH...
Sanofi will present data from across its oncology franchise, including portfolio and pipeline compounds, during the upcoming American Society of...
Sanofi and Regeneron Pharmaceuticals, Inc today announced they have started a clinical program evaluating Kevzara® (sarilumab) in patients...
The U.S. Food and Drug Administration (FDA) has approved Sarclisa® (isatuximab-irfc) in combination with pomalidomide and dexamethasone (pom-dex) for ...
Sanofi U.S. today announced that it has reached an $11.85 million settlement agreement with the federal government to resolve an investigation...
Sleeping naked can help lower your body temperature, which can help you fall asleep faster, and sleep more soundly, which in turn promotes skin...
Sanofi (NASDAQ: SNY; EURONEXT: SAN) Pasteur, the vaccines global business unit of Sanofi, will leverage previous development work for a SARS vaccine...
Sanofi (NASDAQ: SNY; EURONEXT: SAN) Q4 2019 Change Change at CER 2019 Change Change at CER IFRS net sales reported €9,608m +6.8% +4.7% €36,126m +4.8% ...
Olipudase alfa, an investigational recombinant human acid sphingomyelinase, demonstrated positive results in two separate clinical trials evaluating...
Sanofi (NASDAQ: SNY; EURONEXT: SAN) announced today the successful completion of its acquisition of Synthorx, Inc. ("Synthorx") for $68 per share in...
Sanofi Pasteur, the vaccines global business unit of Sanofi, has entered into an agreement with the U.S. Department of Health and Human Services...
Full data from the pivotal Phase 3 CARDINAL trial evaluating the safety and efficacy of sutimlimab in people with primary cold agglutinin disease...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.